{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06056830",
            "orgStudyIdInfo": {
                "id": "CLP04"
            },
            "organization": {
                "fullName": "Clarity Pharmaceuticals Ltd",
                "class": "INDUSTRY"
            },
            "briefTitle": "Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy",
            "officialTitle": "Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy: A Prospective, Single-arm, Multi-center, Blinded-review, Phase 3 Diagnostic Performance Study",
            "acronym": "CLARIFY",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "positron-emission-tomography-using-sar-bispsma-in-participants-with-high-risk-prostate-cancer-prior-to-radical-prostatectomy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-21",
            "studyFirstSubmitQcDate": "2023-09-21",
            "studyFirstPostDateStruct": {
                "date": "2023-09-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Clarity Pharmaceuticals Ltd",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases."
        },
        "conditionsModule": {
            "conditions": [
                "Prostate Cancer",
                "Prostatic Neoplasms"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 383,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "64Cu-SAR-bisPSMA",
                    "type": "EXPERIMENTAL",
                    "description": "200MBq 64Cu-SAR-bisPSMA.",
                    "interventionNames": [
                        "Drug: 64Cu-SAR-bisPSMA"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "64Cu-SAR-bisPSMA",
                    "description": "All Patients will receive a single administration, a bolus injection of 200MBq 64Cu-SAR-bisPSMA.",
                    "armGroupLabels": [
                        "64Cu-SAR-bisPSMA"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases",
                    "description": "Independent primary endpoints for Day 1 and Day 2 PET: Co-primary endpoint of sensitivity and specificity of 64Cu-SAR-bisPSMA PET to detect Prostate Cancer within the pelvic lymph nodes compared to the Standard of Truth.",
                    "timeFrame": "Up to 16 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Safety and tolerability of 64Cu-SAR-bisPSMA",
                    "description": "Incidence and severity of treatment-emergent AEs and SAEs following administration of 64Cu-SAR-bisPSMA",
                    "timeFrame": "Up to 16 weeks"
                },
                {
                    "measure": "Consistency of 64Cu-SAR-bisPSMA PET/CT interpretations for the three central readers",
                    "description": "Inter-reader reliability of agreement estimated with a multiple-reader kappa statistic",
                    "timeFrame": "Up to 16 weeks"
                },
                {
                    "measure": "PPV and NPV of 64Cu-SAR-bisPSMA PET to detect PC within the pelvic LNs",
                    "description": "PPV and NPV of 64Cu-SAR-bisPSMA PET to detect PC within the pelvic LNs compared to the Standard of Truth",
                    "timeFrame": "Up to 16 weeks"
                },
                {
                    "measure": "Ability of 64Cu-SAR-bisPSMA PET to detect Prostate Cancer",
                    "description": "Sensitivity of 64Cu-SAR-bisPSMA PET to detect PC within the prostate gland compared to the Standard of Truth",
                    "timeFrame": "Up to 16 weeks"
                },
                {
                    "measure": "Diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases without subregion matching",
                    "description": "Sensitivity and specificity of 64Cu-SAR-bisPSMA PET to detect PC within the pelvic LNs compared to the Standard of Truth, without the requirement of subregion (Left or Right) matching between 64Cu-SAR-bisPSMA PET and Standard of Truth",
                    "timeFrame": "Up to 16 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* At least 18 years of age.\n* Signed informed consent.\n* Untreated, histologically confirmed adenocarcinoma of the prostate.\n* High-risk or greater PC defined by National Comprehensive Cancer Network Guidelines Version 1.202327 (clinical stage \u2265T3a, or Grade Group \u22654, or PSA \\>20 ng/mL).\n* Patients electing to undergo RP with PLND.\n\nExclusion Criteria:\n\n* Administration of any high energy (\\>300 KeV) gamma-emitting radioisotope within 5 physical half-lives prior to Day 1.\n* Known or expected hypersensitivity to 64Cu-SAR-bisPSMA or any of its components.\n* Patients with known predominant small cell or neuroendocrine PC.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clarity Pharmaceuticals",
                    "role": "CONTACT",
                    "phone": "+61 (0) 2 9209 4037",
                    "email": "clinicaltrials@claritypharmaceuticals.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clarity Pharmaceuticals",
                    "affiliation": "Clarity Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "NorthShore University Health System",
                    "status": "RECRUITING",
                    "city": "Glenview",
                    "state": "Illinois",
                    "zip": "60026",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brian Helfand, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.06975,
                        "lon": -87.78784
                    }
                },
                {
                    "facility": "BAMF Health",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brandon Mancini, MD, MBA",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "Corewell Health",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brian Lane, MD, PhD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Patrik Konomi",
                            "role": "CONTACT",
                            "email": "Patrik.Konomi@corewellhealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "XCancer Omaha LLC",
                    "status": "RECRUITING",
                    "city": "Omaha",
                    "state": "Nebraska",
                    "zip": "68130",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tony Romero",
                            "role": "CONTACT",
                            "phone": "402-991-8468",
                            "email": "tromero@gucancer.com"
                        },
                        {
                            "name": "Luke Nordquist, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.25626,
                        "lon": -95.94043
                    }
                },
                {
                    "facility": "Urologic Specialists",
                    "status": "RECRUITING",
                    "city": "Tulsa",
                    "state": "Oklahoma",
                    "zip": "74146",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shaun GS Grewal, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.15398,
                        "lon": -95.99277
                    }
                },
                {
                    "facility": "Carolina Urologic Research Center",
                    "status": "RECRUITING",
                    "city": "Myrtle Beach",
                    "state": "South Carolina",
                    "zip": "29572",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Neal Shore, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.68906,
                        "lon": -78.88669
                    }
                },
                {
                    "facility": "Urology Clinics of North Texas",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75231",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexander Parker, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "The Urology Place",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78240",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Naveen Kella, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Intermountain Health",
                    "status": "RECRUITING",
                    "city": "Murray",
                    "state": "Utah",
                    "zip": "84107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dustin L. Boothe, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.66689,
                        "lon": -111.88799
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostate Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}